Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues

Journal of Infectious Diseases

Volumn 200, Issue 1, 2009, Pages 11-19

  Remeijer, Lies ^a   Duan, Rui ^a,b   Van Dun, Jessica M ^a,b   Bettink, Mark A Wefers ^a   Osterhaus, Albert D M E ^b   Verjans, Georges M G M ^b  

^a ROTTERDAM EYE HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CORNEA; CORNEA VASCULARIZATION; DISEASE SEVERITY; FEMALE; GRAFT SURVIVAL; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PENETRATING KERATOPLASTY; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STEROID THERAPY; VARICELLA ZOSTER VIRUS; VIRUS CULTURE; VIRUS DETECTION; VIRUS LOAD;

COHORT STUDIES; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; DNA, VIRAL; GRAFT SURVIVAL; HERPES ZOSTER; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 3, HUMAN; HUMANS; KERATOPLASTY, PENETRATING; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 67650667776     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599329     Document Type: Article

References (47)

1. Panda A, Vanathi M, Kumar A, Dash Y, Priya S. Corneal graft rejection. Surv Ophthalmol 2007;52:375-96.
2. Remeijer L, Osterhaus AD, Verjans GM. Human herpes simplex virus keratitis: the pathogenesis revisited. Ocul Immunol Inflamm 2004; 12: 255-85.
3. The Collaborative Corneal Transplantation Studies Research Group. The Collaborative Corneal Transplantation Studies (CCTS). Effective-ness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110:1392-403.
4. Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea 1999; 18:144-54.
5. Liesegang TJ. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 1999; 18:127-43.
6. Koay PY, Lee WH, Figueiredo FC. Opinions on risk factors and management of corneal graft rejection in the United Kingdom. Cornea 2005;24:292-6.
7. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994; 101:1536-47.
8. Foster CS, Duncan J. Penetrating keratoplasty for herpes simplex keratitis. Am J Ophthalmol 1981; 92:336-43.
9. Beekhuis WH, Renardel de Lavalette JG, Schaap GJ. Therapeutic keratoplasty for active herpetic corneal disease: viral culture and prognosis. Doc Ophthalmol 1983;55:31-5.
10. Panda A, Kumar TS. Prognosis of keratoplasty in viral keratitis. Ann Ophthalmol 1991;23:410-3.
11. Vajpayee RB, Sharma N, Sinha R, et al. Infectious keratitis following keratoplasty. Surv Ophthalmol 2007;52:1-12.
12. Lomholt JA, Baggesen K, Ehlers N. Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis. Acta Ophthalmol Scand 1995;73:29-32.
13. Sterk CC, Jager MJ, Swart-vd Berg M. Recurrent herpetic keratitis in penetrating keratoplasty. Doc Ophthalmol 1995;90:29-33.
14. Remeijer L, Doornenbal P, Geerards AJ, et al. Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. Ophthalmology 1997; 104:648-52.
15. Borderie VM, Méritet JF, Chaumeil C, et al. Culture-proven herpetic keratitis after penetrating keratoplasty in patients with no previous history of herpes disease. Cornea 2004;23:118-24.
16. Rezende RA, Uchoa UB, Raber IM, Rapuano CJ, Laibson PR, Cohen EJ. New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty. Am J Ophthalmol 2004; 137:415-9.
17. Remeijer L, Maertzdorf J, Buitenwerf J, et al. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci 2002;43:358-63.
18. Biswas S, Suresh P, Bonshek RE, et al. Graft failure in human donor corneas due to transmission of herpes simplex virus. Br J Ophthalmol 2000;84:701-5.
19. Remeijer L, Maertzdorf J, Doornenbal P, Verjans GM, Osterhaus AD. Herpes simplex virus 1 transmission through corneal transplantation. Lancet 2001; 357:442.
20. Thuret G, Acquart S, Gain P, et al. Ultrastructural demonstration of replicative herpes simplex virus type 1 transmission through corneal graft. Transplantation 2004; 77:325-6.
21. Openshaw H, McNeill JI, Lin XH, et al. Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J Med Virol 1995;46:75-80.
22. van Gelderen BE, Van der Lelij A, Treffers WF, van der Gaag R. Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons. Br J Ophthalmol 2000;84:1238-43.
23. Kaye SB, Baker K, Bonshek R, et al. Human herpesviruses in the cornea. Br J Ophthalmol 2000;84:563-71.
24. Robert PY, Adenis JP, Denis F, et al. Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients. J Med Virol 2003;71:69-74.
25. Shimomura Y, Deai T, Fukuda M, Higaki S, Hooper LC, Hayashi L. Corneal buttons obtained from patients with HSK harbor high copy numbers of the HSV genome. Cornea 2007;26:190-3.
26. Verjans GM, Hintzen RQ, van Dun JM, et al. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci U S A 2007; 104:3496-501.
27. Doornenbal P, Seerp Baarsma G, Quint WG, Kijlstra A, Rothbarth PH, Niesters HG. Diagnostic assays in cytomegalovirus retinitis: detection of herpesvirus by simultaneous application of the polymerase chain reaction and local antibody analysis on ocular fluid. Br J Ophthalmol 1996;80:235-40.
28. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003; 41: 3221-8.
29. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003;41:576-80.
30. Cohrs RJ, Randall J, Smith J, et al. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol 2000; 74: 11464-71.
31. Loutsch JM, Sainz B Jr, Marquart ME, et al. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits. Antimicrob Agents Chemother 2001;45:2044-53.
32. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. Knipe DM, Howley P, eds. In: Fields virology. Philadelphia: Lippincott Williams & Wilkins, 2007:2502-76.
33. O'Day D. Diseases potentially transmitted through corneal transplantation. Ophthalmology 1989;96:1133-7.
34. Asimakis P, Kirkness CM. Storage of donor corneas, surgery, outcome, and complications of penetrating keratoplasty. Curr Opin Ophthalmol 1996; 7:35-40.
35. Cohen JI, Straus SE, Arvin AM. Varicella zoster virus: replication, pathogenesis and management. In: Knipe DM, Howley P, eds. Fields virology. Philadelphia: Lippincott, Williams & Wilkins, 2007:2773-818.
36. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci 2005;46:241-7.
37. Toma HS, Murina AT, Areaux RG Jr, et al. Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol 2008; 23:249-73.
38. Kaye SB, Lynas C, Patterson A, Risk JM, McCarthy K, Hart CA. Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol 1991;75:195-200.
39. Perng GC, Zwaagstra JC, Ghiasi H, et al. Similarities in regulation of the HSV-1 LAT promoter in corneal and neuronal cells. Invest Ophthalmol Vis Sci 1994;35:2981-9.
40. Zheng X. Reactivation and donor-host transmission of herpes simplex virus after corneal transplantation. Cornea 2002;21:S90-3.
41. Biswas PS, Rouse BT. Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect 2005;7:799-810.
42. Guess S, Stone DU, Chodosh J. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf 2007;5:240-50.
43. Butler TK, Spencer NA, Chan CC, Singh Gilhotra J, McClellan K. Infective keratitis in older patients: a 4 year review, 1998-2002. Br J Ophthalmol 2005;89:591-6.
44. van der Meulen IJ, van Rooij J, Nieuwendaal CP, Van Cleijnenbreugel H, Geerards AJ, Remeijer L. Age-related risk factors, culture outcomes, and prognosis in patients admitted with infectious keratitis to two Dutch tertiary referral centers. Cornea 2008; 27:539-44.
45. Turner J, Turner OC, Baird N, Orme IM, Wilcox CL, Baldwin SL Influence of increased age on the development of herpes stromal keratitis. Exp Gerontol 2003;38:1205-12.
46. Kumar R, Burns EA. Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev Vaccines 2008; 7:467-79.
47. Sheridan BS, Knickelbein JE, Hendricks RL. CD8 T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia. Expert Opin Biol Ther 2007;7:1323-31.